中国肝脏病杂志(电子版)
中國肝髒病雜誌(電子版)
중국간장병잡지(전자판)
CHINESE JOURNAL OF LIVER DISEASES(ELECTRONIC VERSION)
2014年
1期
5-7
,共3页
郭换珍%赵直光%唐中权%安纪红%孟江涛%倪文
郭換珍%趙直光%唐中權%安紀紅%孟江濤%倪文
곽환진%조직광%당중권%안기홍%맹강도%예문
肝肿瘤%三氧化二砷%治疗学
肝腫瘤%三氧化二砷%治療學
간종류%삼양화이신%치료학
Liver neoplasms%Arsenic trioxide%Therapeutics
目的:探讨三氧化二砷(As2O3)治疗晚期原发性肝癌(PLC)的临床价值。方法将48例患者随机分为治疗组(26例)和对照组(22例)。两组患者在保肝、抗病毒、支持对症等治疗基础上,治疗组加用As2O310 mg,10%葡萄糖注射液500 ml,每日1次静脉输注,每2周为1个疗程,间隔2周进行下一个疗程,共2个疗程,观察结束复查并进行疗效评估。结果两组患者观察结束的客观有效率、获益率分别为0.0%、19.2%(P=0.0376)和22.8%、53.8%(P=0.0083),两组患者生活质量改善和稳定率分别为31.8%和65.4%(P=0.0291)。结论As2O3治疗晚期PLC具有一定的临床价值,对于肝功能差且无法耐受其他治疗的PLC患者,As2O3仍不失是一种较有效的治疗手段。
目的:探討三氧化二砷(As2O3)治療晚期原髮性肝癌(PLC)的臨床價值。方法將48例患者隨機分為治療組(26例)和對照組(22例)。兩組患者在保肝、抗病毒、支持對癥等治療基礎上,治療組加用As2O310 mg,10%葡萄糖註射液500 ml,每日1次靜脈輸註,每2週為1箇療程,間隔2週進行下一箇療程,共2箇療程,觀察結束複查併進行療效評估。結果兩組患者觀察結束的客觀有效率、穫益率分彆為0.0%、19.2%(P=0.0376)和22.8%、53.8%(P=0.0083),兩組患者生活質量改善和穩定率分彆為31.8%和65.4%(P=0.0291)。結論As2O3治療晚期PLC具有一定的臨床價值,對于肝功能差且無法耐受其他治療的PLC患者,As2O3仍不失是一種較有效的治療手段。
목적:탐토삼양화이신(As2O3)치료만기원발성간암(PLC)적림상개치。방법장48례환자수궤분위치료조(26례)화대조조(22례)。량조환자재보간、항병독、지지대증등치료기출상,치료조가용As2O310 mg,10%포도당주사액500 ml,매일1차정맥수주,매2주위1개료정,간격2주진행하일개료정,공2개료정,관찰결속복사병진행료효평고。결과량조환자관찰결속적객관유효솔、획익솔분별위0.0%、19.2%(P=0.0376)화22.8%、53.8%(P=0.0083),량조환자생활질량개선화은정솔분별위31.8%화65.4%(P=0.0291)。결론As2O3치료만기PLC구유일정적림상개치,대우간공능차차무법내수기타치료적PLC환자,As2O3잉불실시일충교유효적치료수단。
Objective To investigate the effect of arsenic trioxide (As2O3) in treatment of advanced primary liver carcinoma (PLC). Methods Total of 48 cases of advanced PLC were randomly divided into the treatment group (26 cases) and control group (22 cases). The two groups received basic hepatoprotective, antiviral, symptomatic of the treatment group was added with As2O3 10 mg, 10%glucose injection 500 ml, intravenous drip once a day, every two weeks for one courses, two weeks apart, for a course of treatment, a total of two courses. An observation is checked and curative effect evaluation. Results The two groups of patients were observed at the end of the objective efifciency, beneift rate were 0%, 19.2%and 22.8%(P=0.0376), 53.8%(P = 0.0083), two groups of patients and improve quality of life, stable rate were 31.8%and 65.4%(P=0.0291). Conclusions As2O3 treatment has a certain clinical value for advanced PLC, liver function is poor, unable to tolerate other treatment of patients with PLC, As2O3 is a more effective treatment.